AGM
FCSC

Alpine Global Management’s Fibrocell Science Inc. FCSC Stock Holding History

Alpine Global Management’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,137
Closed -$37K – 198
2016
Q2 		$37K Buy
+2,137
New +$66.6K 0.02% 176

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alpine Global Management's FCSC Position: Q3 2016 in Review

Alpine Global Management sold out of Fibrocell Science Inc. (FCSC) in Q3 2016, closing a stake of 2,137 shares — an estimated $37K sold.

Alpine Global Management first reported a position in FCSC in Q2 2016 and held it in 1 quarter. The position peaked at $37K in Q2 2016. 37 funds tracked by Wall St. Rank hold FCSC as of Q3 2016.

  • Alpine Global Management reported no remaining Fibrocell Science Inc. position as of Q3 2016 after selling out during the quarter.
  • Alpine Global Management sold 2,137 Fibrocell Science Inc. shares in Q3 2016, an estimated $37K.
  • Alpine Global Management first reported a position in Fibrocell Science Inc. in Q2 2016 and held it in 1 quarter.
  • Alpine Global Management's Fibrocell Science Inc. position peaked at $37K in Q2 2016.
  • 37 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2016.

Based on Alpine Global Management's 13F filing for Q3 2016, filed 15 Nov 2016.